Related references
Note: Only part of the references are listed.Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
Andrew Lotery et al.
LANCET (2020)
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial
Thomas J. van Rijssen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
Thomas J. Van Rijssen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage
Thomas J. van Rijssen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy
Sarah Mrejen et al.
OPHTHALMOLOGY (2019)
Long-Term Efficacy and Safety of Photodynamic Therapy in Patients With Chronic Central Serous Chorioretinopathy
Young Jon Park et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2019)
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group
Jose A. Roca et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
Thomas J. van Rijssen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial
Elon H. C. van Dijk et al.
OPHTHALMOLOGY (2018)
Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
Thomas J. van Rijssen et al.
PLOS ONE (2018)
NONDAMAGING RETINAL LASER THERAPY FOR TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY What is the Evidence?
Edward H. Wood et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
Myrte B. Breukink et al.
CLINICAL OPHTHALMOLOGY (2017)
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Frank H. P. Lai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy
Paula Scholz et al.
OPHTHALMOLOGICA (2015)
One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Kyoko Fujita et al.
OPHTHALMOLOGY (2015)
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Alejandra Daruich et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2015)
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
Myrte B. Breukink et al.
TRIALS (2015)
Association Between the Efficacy of Half-Dose Photodynamic Therapy With Indocyanine Green Angiography and Optical Coherence Tomography Findings in the Treatment of Central Serous Chorioretinopathy
Massimo Nicolo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Non-damaging Retinal Phototherapy: Dynamic Range of Heat Shock Protein Expression
Christopher Sramek et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Central Serous Chorioretinopathy: A Personal Perspective
Lawrence A. Yannuzzi
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Association Between the Efficacy of Photodynamic Therapy and Indocyanine Green Angiography Findings for Central Serous Chorioretinopathy
Ryo Inoue et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Subfoveal Choroidal Thickness after Treatment of Central Serous Chorioretinopathy
Ichiro Maruko et al.
OPHTHALMOLOGY (2010)
Diffuse chronic retinal pigment epitheliopathy and exudative retinal detachment
Leila Laatikainen
ACTA OPHTHALMOLOGICA (2009)
Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy
F. Ricci et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy: A pilot study
P. Lanzetta et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2008)
Subthreshold Diode Micropulse Photocoagulation for the Treatment of Chronic Central Serous Chorioretinopathy with Juxtafoveal Leakage
San-Ni Chen et al.
OPHTHALMOLOGY (2008)
Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
WM Chan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy - A pilot study
LA Yannuzzi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2003)
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy
RH Loo et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2002)
Development of the 25-item National Eye Institute Visual Function Questionnaire
CM Mangione et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Share Paper
